Skip to content
2000
Volume 9, Issue 18
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

A series of potential topoisomerase II-mediated anticancer 9-anilinoacridine derivatives, which are designed to avoid bio-oxidation and possessed long duration of drug action, is reviewed. Among these agents, 3-(9-acridinylamino)-5- hydroxymethylaniline (AHMA) derivatives and their alkylcarbamates have been investigated and developed for potential clinical application.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867023369231
2002-09-01
2025-04-19
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867023369231
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test